TG6-44 treatment decreases IFN-β levels in A/X31-infected THP-1 cells. by Juan A. De La Cruz (11154187)

Measurement of the mitochondrial superoxide anion production in HL-1 cells exposed to LG, NG, HG and IHG between short- (12h) and long-time (72h) glucose treatment. by Patrick Mordel (17020879)

Loss of virulence in the SIN kinase mutants is characterized by decreased fungal burden and host response to infection. by Ana Camila Oliveira Souza (8180958)

“…Data are represented as nanograms of <i>A</i>. <i>fumigatus</i> specific DNA in 500 ng of total DNA. * p < 0.02. …”

Comparison of oxidized proteins extracted from HL-1 cells exposed to LG, NG, HG and IHG between short- (12h) and long-time (72h) glucose treatment. by Patrick Mordel (17020879)

Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on bacterial load after cecal ligation and puncture (CLP)-induced sepsis. by Daniel Siegl (717509)

Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on inflammatory mediators after cecal ligation and puncture (CLP)-induced sepsis. by Daniel Siegl (717509)

Decrease in number of activated macrophages in demyelinated nerves subjected to 1hr ES. by Nikki A. McLean (643606)

“…Note: ES results in a significant decrease in the ED-1 IF 10d post-LPC (5d post-ES; K) and 12d post-LPC (7d post-ES; N) relative to LPC only in a pattern suggestive of movement toward lateral edges and egress (arrow). …”

Binding of <i>PC3/Tis21</i> to the <i>Id3</i> promoter and corresponding decrease of <i>Id3</i> mRNA. by Stefano Farioli-Vecchioli (256006)

“…(<b>A</b>) PC12 cells without (white columns) or with expression of exogenous <i>PC3</i> (activated a week before by withdrawal of 2 µg/ml of doxycycline; grey columns) were exposed to NGF (100 ng/ml) for 1 and 48 hours. …”

Fig 5 - by Héctor Raúl Olivares-Sánchez (13014866)

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A₁₆₅b relative to total VEGF-A₁₆₅ (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A₁₆₅b before stripping and reprobing with panVEGF-A). …”

Decreased BP in female mice with cardiac-specific inactivation of <i>Prdm16</i>. by Ji-One Kang (844616)

Green tea polyphenols decrease cell viability and induces apoptosis in LNCaPshV and LNCaPshp53 cells. by Karishma Gupta (293144)

Effect of pyruvic acid on ATP production and A1254-induced decrease of membrane mitochondrial potential (mΔΨ) in SH-SY5Y cells. by Stefania Cocco (759155)

Decrease of rRNAs and ribosomal proteins in <i>L</i>. <i>(V</i>.<i>) braziliensis</i> amastigotes. by Marlene Jara (774474)

U937 cells line transfected with miR-525-5p decrease VPAC1 protein at 48 h. by Elisa Cocco (362650)

Activation of Wnt/β-catenin signaling decreases mRNA expressions of <i>Scx</i>, <i>Mkx</i> and <i>Tnmd</i> in rat TDCs. by Yasuzumi Kishimoto (4282138)

“…<p>Relative expressions of <i>Axin2</i>, <i>Scx</i>, <i>Mkx</i>, and <i>Tnmd</i> in TDCs treated with 50 ng/ml Wnt3a with or without 5 μM IWR (an inhibitor of β-catenin) <b>(A)</b>, 0 to 4 μM BIO (an activator of β-catenin) <b>(B)</b>, or 0 to 20 μM IWR <b>(C)</b> for 72 hrs. …”

Glucose decreases the ability of HNF4α to activate the transcription of the <i>NR2F2</i> proximal promoter and to bind its chromatin target. by Marie Boutant (164748)

Infection with BVDV R₂, R₃ and R₅ leads to a decrease in dead cells. by Eliana F. Castro (581093)

p7 ATMI mutant viruses display increased E2 secretion and decreased RNA and core secretion. by Solène Denolly (4692070)

Pretreatment of Huh-7.5.1 cells with PF-429242 results in a robust decrease in intracellular viral RNA for all four DENV serotypes. by Anastasia Hyrina (3860455)